When to Retest After Treatment for Gonorrhea
Retest all patients with gonorrhea 3 months after treatment, regardless of whether they believe their sex partners were treated. 1
Rationale for 3-Month Retesting
The high prevalence of reinfection drives this recommendation:
- Most post-treatment infections represent reinfection rather than treatment failure, indicating inadequate partner treatment or new exposures 1
- Patients who have had gonorrhea face substantially elevated risk of acquiring a new infection in the subsequent months 1
- This retesting is distinct from test-of-cure, which is not recommended for patients treated with standard regimens 1
Test-of-Cure: When It Is NOT Needed
Patients with uncomplicated gonorrhea treated with recommended regimens (ceftriaxone plus azithromycin) do not require test-of-cure. 1, 2
Test-of-Cure: When It IS Required
Test-of-cure is mandatory in specific circumstances:
- Alternative regimens: Patients receiving cefixime or azithromycin monotherapy require test-of-cure at 1 week after treatment 2
- Persistent symptoms: Any patient with ongoing symptoms after treatment should undergo culture with antimicrobial susceptibility testing 1, 2
- Pharyngeal infections treated with spectinomycin: Test pharyngeal culture 3-5 days after treatment due to only 52% efficacy 1, 2
- Suspected treatment failure: Obtain culture with susceptibility testing immediately and report to public health within 24 hours 2
Timing Considerations
- Test-of-cure timing: When required, perform at 1 week for alternative regimens or 2 weeks for nucleic acid amplification tests (NAATs) 2, 3
- Reinfection screening: 3 months after treatment for all patients 1
- Opportunistic testing: If patients don't return at 3 months, test whenever they next seek care within 12 months 1
Special Population: Pregnant Women
Pregnant women require more intensive follow-up:
- Retest in the third trimester if antenatal gonococcal infection was diagnosed, unless recently treated 4
- For first-trimester diagnosis, retest 3 months after treatment 1
Common Pitfalls to Avoid
- Do not confuse test-of-cure with reinfection screening: Test-of-cure detects treatment failure (rarely needed); 3-month retesting detects reinfection (always recommended) 1
- Do not skip retesting based on partner treatment status: High reinfection rates occur even when patients report partner treatment 1
- Do not use NAATs too early: If test-of-cure is needed, wait at least 2 weeks to avoid false-positive results from residual nucleic acid 3
- Do not forget to test for other STIs: Screen for chlamydia, syphilis, and HIV at the time of gonorrhea diagnosis and retesting 2, 5